Attend 2 Asthma
3 people die from asthma each day in the UK despite up to 90% of asthma deaths being associated with preventable factors.
Attend2: Asthma is a clinical platform developed by Interface Clinical Services that can be used to support the management of patients with asthma.
Attend2: Asthma is underpinned by national and international guidelines (including BTS/SIGN 153 and NICE NG80) and is used to identify patients who may benefit from a review of their current management strategy. Attend2: Asthma performs a comprehensive stratification of patients with asthma across a healthcare organisation’s patient database, taking into account a patient’s current level of symptom control and treatment, concordance and co-morbidities. Stratifying patients according to the level of clinical need allows practices to more effectively plan and prioritise their workload.
Details of reviews and interventions can be logged against individual patients within the Attend2: Asthma platform. Dynamic reporting provides a detailed before and after analysis of practice asthma management. This can be used as part of the clinical audit cycle to evaluate change and demonstrate quality improvement in the care of patients with asthma.
We were very impressed with the pharmacist’s efficiency and clear knowledge of such an important clinical subject, and we have had great feedback from the patients that attended the asthma clinics. We would gladly have you back to more work for us.
Interface takes the spread of COVID-19 extremely seriously. Our priority is the safety of patients, employees, NHS staff and their families. We’re adapting our services to deliver clinical support remotely including the patient clinics incorporated within many of our reviews.Learn more